Sign in to continue:

Wednesday, March 4th, 2026

Daktronics, Inc. Reports Q3 Fiscal 2026 Results: Revenue, Segment Performance, and Business Highlights





Daktronics Inc. Q3 Fiscal 2026 Earnings Detailed Report

Daktronics Inc. Reports Strong Q3 Fiscal 2026 Results: Sales Surge, Operating Income Turns Positive

Key Highlights for Investors

  • Sales Growth: Daktronics reported net sales of \$181.9 million for Q3 FY2026, representing a robust 21.6% increase from \$149.5 million in Q3 FY2025.
  • Operating Income Rebound: The company achieved an operating income of \$1.9 million for the quarter, a significant turnaround from an operating loss of \$3.6 million in the prior-year quarter.
  • Net Income Surges: Net income for the quarter reached \$3.0 million, compared to a net loss in the previous corresponding period. For the nine months ended January 31, 2026, net income soared to \$37.0 million.
  • Gross Profit Improvement: Gross profit rose to \$43.6 million in the quarter, up from \$31.9 million a year earlier.
  • Strong Cash Flows: Free cash flow for the nine months ended January 31, 2026, was an impressive \$44.5 million. Net cash provided by operating activities in this period was \$74.8 million.
  • Healthy Balance Sheet: As of January 31, 2026, total assets stood at \$546.4 million with stockholders’ equity at \$293.7 million.
  • Share Buybacks: The company repurchased a significant amount of its own shares, spending \$22.8 million over the nine months. Treasury stock increased from 3.98 million shares to 5.27 million shares, representing a notable reduction in shares outstanding.

Details and Analysis

Daktronics Inc. announced a strong set of results for its third quarter of fiscal 2026, ended January 31, 2026. The company’s sales momentum has continued, reflecting both robust end-market demand and execution on growth initiatives.

The 21.6% year-over-year sales growth was a standout, showing that Daktronics is winning new business and capitalizing on sustained demand for its electronic display solutions. Gross margin expansion accompanied the sales growth, with gross profit rising to \$43.6 million.

A major turning point for investors is the swing to positive operating income. The company reported a \$1.9 million operating profit versus a loss in the same period last year, indicating that cost management and operational efficiency initiatives are delivering results.

Net income for the quarter was \$3.0 million, and for the nine months, net income reached \$37.0 million. This turnaround is reflected in EPS improvements and could be a catalyst for further share price appreciation if the trend continues.

Cash flow generation has been strong. For the nine-month period, Daktronics reported \$74.8 million in net cash from operating activities and \$44.5 million in free cash flow, providing room for strategic investments and shareholder returns.

Capital allocation is active: The company deployed \$22.8 million to repurchase its own shares, a move that can boost EPS and is often seen as a sign of management’s confidence in the business outlook.

The balance sheet remains solid, with total assets of \$546.4 million and stockholders’ equity of \$293.7 million as of January 31, 2026. Long-term debt was manageable at \$9.9 million, and cash and cash equivalents were strong.

Price-Sensitive and Shareholder-Relevant Information

  • Return to Profitability: The transition from operating losses to profits is highly price-sensitive and may support a re-rating of the stock.
  • Share Buybacks: Aggressive share repurchases can increase per-share earnings and signal management’s confidence, potentially impacting share value.
  • Cash Generation: Robust free cash flow and operating cash flows provide flexibility for future capital allocation, dividends, and further buybacks.
  • Non-GAAP Metrics: The company provides adjusted operating income and net income metrics, excluding non-recurring items, which were higher than GAAP figures and may be used by investors to assess ongoing performance.
  • Risks and Outlook: Management notes ongoing monitoring of tariffs, component costs, and global trade dynamics. The company is taking steps in pricing, supply chain, and contractual protections to mitigate these risks. Shareholders should watch for regulatory or geopolitical developments that could affect margins or sales.
  • Leadership and Strategy: The report references a recent leadership transition and ongoing transformation initiatives, which could impact future strategy and performance.

Non-GAAP Measures and Reconciliations

Daktronics provides certain non-GAAP financial measures, such as adjusted operating income, margin, and net income, to help investors analyze the business excluding non-recurring or non-core items. For Q3 FY2026, adjusted operating income was \$4.0 million, and for the nine months, \$35.2 million. This approach gives a clearer view of ongoing profitability trends and may influence market perceptions.

The company also highlights its methodology for order and backlog metrics, noting these are not GAAP-defined and may differ from competitors’ reporting.

Risks and Forward-Looking Statements

Management cautions that results could differ from expectations due to factors such as economic and market conditions, timing and size of contracts, new product introductions, weather, tariffs, raw material and shipping costs, global events, and leadership changes. Investors should consider these risks when evaluating the company’s outlook.

Contact and Additional Information

For more information, investors can contact Howard I. Atkins, Acting Chief Financial Officer, at (605) 692-0200, or email [email protected]. Alliance Advisors IR, represented by Carolyn Capaccio and Jody Burfening, is also available for investor relations inquiries.


Disclaimer: This article summarizes financial results and company disclosures provided by Daktronics Inc. Investors are advised to review the full filings and consider all associated risks before making investment decisions. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. This is not investment advice.




View DAKTRONICS INC /SD/ Historical chart here



Geron Corporation 2025 Annual Report: RYTELO Commercialization, Risks, and Business Overview

Company Overview Geron Corporation (Nasdaq: GERN) is now a commercial-stage biopharmaceutical company, focused on changing the treatment landscape for hematologic malignancies and other cancers. The company’s main product, RYTELO™ (imetelstat), has reached commercial launch...

Honeywell Files Form 10 for Planned Spin-Off of Honeywell Aerospace, Creating Major Pure-Play Aerospace & Defense Company in 2026

Honeywell Announces Major Spin-Off of Aerospace Business – Detailed Investor Update Honeywell Announces Major Spin-Off of Aerospace Business – Detailed Investor Update Key Highlights and Investor-Relevant Details Honeywell Files Form 10 for Aerospace Spin-Off:...

Senseonics Reports Strong 2025 Financial Results with 72% Q4 Revenue Growth, Eversense 365 CE Mark Approval, and Positive 2026 Outlook

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results: Strong Growth, Strategic Moves, and Ambitious 2026 Outlook Germantown, Md. – March 2, 2026: Senseonics Holdings, Inc. (NASDAQ: SENS), a leading medical...

   Ad